Dr. Yang is the co-founder and Chairman of Board, BGI, one of the major genomics centers in the world. He and his partners have made a significant contribution to the International HGP, HapMap Project, 1000 Genomes Project, and other human omics research, as well as sequencing and analyzing genomes of many other animals, plants, and microorganisms, with many publications in Science, Nature, Cell and other internationally prestigious journals.

Dr. Yang obtained his Ph.D. from University of Copenhagen (Denmark) and postdoctoral trainings in France and USA. He has received many awards and honors, including Research Leader of the Year by Scientific American in 2002 and Award in Biology by the Third World Academy of Sciences (TWAS) in 2006. He was elected as a foreign member of European Molecular Biology Organization (EMBO) in 2006, an academician of Chinese Academy of Sciences in 2007, a fellow of TWAS in 2008, a foreign academician of Indian National Science Academy in 2009, German National Academy of Science in 2012 and the USA National Academy of Science in 2014. 

Honors and Awards(Partial)

1994 Awarded for Outstanding Young Talent by National Natural Science Foundation of China.
2002 Received National Natural Science Award (2nd) by Ministry of Science & Technology, China.
2002 Awarded for Outstanding Team in Science & Technology Achievement by “Qiu Shi” Science & Technologies Foundation, Hongkong.
Received Research Leader of the Year by Scientific American.
2003 Awarded Nikkei Asia Prize for Science by Nihon KeizaiShimbun, Inc. Japan.
2003 Awarded Nihon KeizaiShimbun, Inc. Japan by Nihon KeizaiShimbun, Inc. Japan.
2003 Awarded Outstanding Award against SARS by Chinese Association of Science and Technology.
2003 Awarded for Outstanding Team in Science & Technology Achievements by Chinese Academy of Sciences (CAS).
2004 Awarded TWAS Prize for Biology by The Academy of Sciences for the Developing World (TWAS).
2004 Awarded  H & H Prize by H& H Foundation, Hongkong.
2006 Received Award in Biology by the Third World Academy of Sciences (TWAS) .
Received the Chen Award for Distinguished Academic Achievement in Human Genetic and Genomic Research at the 2011 Human Genome Meeting (HGM).
Elected as a member of the German National Academy of Sciences, on account of his outstanding contributions to the field of Human Genomics and Genetics.
The book “Reproduction and Cloning, Natural or Artificial”, written by Professor Huanming Yang, won the 2012 National Science and Technology Progress Award.
Listed as Thomson Reuters’ Highly Cited Researchers


Wang Jian is the President of BGI. He graduated from Central South University in 1979 and obtained his master’s degree from Beijing University of Chinese Medicine. After graduation, he performed postdoctoral research at the University of Texas and the University of Iowa from 1988 to 1990. He worked as a senior research fellow at the University of Washington between 1990 and 1994. From 1997, he participated in Human Genome Project working closely with Huanming Yang and co-founded BGI . Since 1999, he acted as the main initiator of many international research projects including the International 1000 Genomes Project, the Rice Genome Project, the Silkworm Genome Project etc. He has published papers in many international journals and conducted various key national projects.

Honors and Awards(Partial)
The Advanced Group of 1% of Human Genome Project for the 15th Anniversary of National 863 Program Award granted by the Ministry of Science and Technology, P.R.C.
Beijing first “entrepreneurship prize” for returned from study abroad.
Outstanding Scientific Research Team Award, Hong Kong Qiu shi Science and Technologies Foundation.
Advanced individual of anti-SARS team in the Capital.
Major Innovative Contribution Team of 2001-2002, granted by Chinese Academy of Science.
Received the Illustrious Scientific Achievement Award of Chinese Academy of Science (Outstanding contributor).
2nd prize of Beijing Science and Technology Award for his research on SARS coronovirus genome sequencing and ELISA diagnosis kit.
Received the first “Outstanding enterpreneurship Award”for overseas Chinese professionals.
Received the Advance Group Medal of Chinese Medical Rescue Team in Indian Ocean Tsunami granted by Chinese Committee of Education, Science, Culture, Health and Sports.
Received the City’s Innovation Award of Technology for the research project of “The Diploid Genome Sequence of an Asian Individual” granted by Shenzhen Government.
Received the City’s Natural Science Award for the research project of “Panda genome sequence map”granted by Shenzhen Government.
Received the City’s Enviornment Protection Award granted by Shenzhen Government.
Received the Citiy’s Technology Innovation Award for the research project of “Genome short sequence mono-nucleotide analysis method and system” granted by Shenzhen Government.
“Outstanding Talent” granted by Yantian District, Shenzhen
Received 2nd prize of Science and Technology Award Natrual Science division for the project “The first Asian Individual genome map”granted by Guangdong Province
Received Chinese Cooperative Innovation Achievement Award  for “Genome short sequence mono-nucleotide analysis method and system”
Listed as Thomson Reuters’ Highly Cited Researchers.

Yonghong Mei is Director of China National GeneBank, Chairman and CEO of BGI Agriculture Group. He graduated from Department of Agronomy, Huazhong Agricultural University. He served as Director of Policies, Regualtions and Reform in Ministry of Science and Technology, Deputy Party Secretary and Mayor of Jining City.   

During his tenure in Ministry of Science and Technology, he was engaged in strategic research, policies, regulations, reform and talents management. He has made contributions to the establishment and implement of national self-dependent innovation. 
During his tenure in Jining city, he endeavored to promote industrial structural transformation, develop modern service industry, and facilitate scientific and technological progress.

Shuang Yang is CEO of BGI. In 1999, while studying for his master’s degree, Shuang Yang completed “SERT Genome Sequence and SNP classification project” for mentally ill patient groups in Chinese National Human Genome Center at Shanghai. In 2002, he joined Kunming Institute of zoology CAS for evolutionary genomics research. Since his joining BGI in 2005, he has participated and led many national projects including 973 Project and 948 Plan, as well as several other research and projects on healthcare management and major diseases. He has published papers in Nature, PLOS Genetics and other internationally prestigious journals.


Xun Xu is Executive Vice President of BGI and Director of BGI-Shenzhen. He leads the research and development activities in genomics and other omics field. He has successfully organized and finished genetic diversity map projects for rice, soybean, corn, silkworms, and led the studies on evolutionary analysis. He also successfully coordinated the genome consortiums for the potato, cabbage, CHO, sheep, goat project, etc. 

He built the single cell sequencing platform in BGI and carried out a comprehensive analysis on the cell lineage of cancer cell populations, which reflected possible history about the cancer progression. 

He has already had 9 patents as the inventor and another 44 is in application. He has been leading the research team to publish a lot of high impact papers, among which 12 are listed as first author and 16 are corresponding author. 

He now also leads the team on developing BGI sequencers.

Honors and Awards (Partial):

2012 Part-time professor at Wuhan University
2013 Honorary Assistant Professor of The University of Hong Kong

Yanmei Zhu is Executive Vice President of BGI and Director of Strategic Planning Committee of BGI. Zhu obtained PhD. From both Tongji University and Swiss Federal Institute of Technology University.

Zhu Yanmei previously served as the Project Director in the headquarters of The Southern Securities Investment Bank; Vice Dean of School of Economics and Management at Tongji University; Executive Dean of Chinese Academy of Science and Technology Management at Tongji University. She was appointed as Vice-director of Yangpu District Development and Reform Commission, Shanghai City. During 2005-2007, she was a visiting scholar of Swiss Federal Institute of Technology in Zurich. She was also a member of the 6th CPPCC of Shenzhen.


Yu Tak Kin, the Chief Operating Officer of BGI and oversees BGI International Development Centre, joined BGI in 2014.

Yu Tak Kin graduated from Biochemistry in the University of Iowa in 1991. Prior to joining BGI, he worked in GE Healthcare and Amersham Biosciencesia Pacific and Fareast. He took up various key leadership roles in China and Asia Pacific, as General Manager and Marketing Leader for Life Sciences in Greater China, and Business Director in Discovery Systems and Genomics & Proteomics.

Feng Mu is Executive Vice President of BGI. He obtained his PhD from Chinese Academy of Science. He joined BGI in 1998 and served as GBI General Manager, Vice President of BGI-Health, General Manager of BGI-Central and BGI-Northern, etc. He has abundant experiences on company operation, science and technology research, production and quality management, project management and implementation. 

He participated in many important projects, such as Human Genome Project (HGP), The International HapMap Project, rice, silkworm, millions genomes project and other large-scale genome research programs. He also played important role in science and industrial programs, such as HIV, syphilis, SARS, autoimmune, respiratory viruses, tumor markers, next-generation sequencing technology application and others. 
He has published papers in the journal of Nature, Plos etc. and obtained over a hundred new drug certificates, registration certificates and patents. 

Yingjun Sun is Executive Vice President of BGI. He obtained Master of Economics from Fudan University and Master of Business Administration from University of Wales.

He joined BGI in 2001 and served as Chief Financing Officer since 2007. He is responsible for investment and financing management. He also participated in strategy making, asset structure optimization, improvement of assets operational efficiency, and reduction of operational cost.

Ye Yin is CEO of BGI Genomics Co., Ltd. He joined BGI in 2002 and played an indispensable role in fighting against SARS, which has become his first achievement in the early career. He has been in charge of all the scientific collaboration business worldwide, from sales activities to market management, and to technical support in BGI. With BGI’s rapid development into the world-leading organization in genomic field and into diagnostics and agriculture industry, he contributed in the acquisition of Complete Genomics in 2013 and the smooth merge of CG with BGI.

Ye has abundant experiences on massive lab production and quality management. He has successfully guided several international projects, like “1000 Plant and Animal Reference Genomes project”, “One Million Human Genomes re-sequencing project” and so on. He has several publications of genome research projects and genetic insights into medical research.